This list is an analysis based on recent market events. It's not an investment recommendation.
About
Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia.
The current price of NXN.AU is A$0.16 AUD — it has increased by +0% in the past 24 hours. Watch Nexsen stock price performance more closely on the chart.
What is Nexsen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Nexsen stocks are traded under the ticker NXN.AU.
Is Nexsen stock price growing?▼
NXN.AU stock has risen by +0% compared to the previous week, the month change is a +23.08% rise, over the last year Nexsen has showed a -21.95% decrease.
What is Nexsen market cap?▼
Today Nexsen has the market capitalization of 32.03M
What is Nexsen revenue for the last year?▼
Nexsen revenue for the last year amounts to 501,000 AUD.
What is Nexsen net income for the last year?▼
NXN.AU net income for the last year is -4.18M AUD.